Signs, Symptoms and Treatment of Fibromyalgia
May 20, 2012 by biobs2 | 1 Comment
Fibromyalgia is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues. Researchers believe that fibromyalgia amplifies painful sensations by affecting the way your brain processes pain signals. It is more prevalent in women than men. It affects more than 6 million people in the United States alone.
Signs and Symptoms
Fibromyalgia is a chronic condition that causes pain, stiffness, and tenderness of the muscles, tendons, and joints. Fibromyalgia is also characterized by restless sleep, awakening feeling tired, chronic fatigue, anxiety, depression and disturbances in bowel function. Fibromyalgia is sometimes referred to as fibromyalgia syndrome and abbreviated FMS. Fibromyalgia was formerly known as fibrositis.
Fibromyalgia is one of the most common diseases affecting the muscles leading to chronic pain and disability. Currently, its cause is currently unknown. The painful tissues involved are not accompanied by tissue inflammation. Therefore, despite potentially disabling body pain, patients with fibromyalgia do not develop body damage or deformity.
Fibromyalgia also does not cause damage to internal body organs. In this sense, fibromyalgia is different from many other rheumatic conditions (such as rheumatoid arthritis, systemic lupus, and polymyositis). In those diseases, tissue inflammation is the major cause of pain, stiffness, and tenderness of the joints, tendons and muscles, and it can lead to joint deformity and damage to the internal organs or muscles.
Medications and Treatments
Medications and treatments, along with pain management techniques like relaxation, pacing, and exercise, can play a big role in reducing pain and improving quality of life.
Traditionally, the most effective medications in the treatment of fibromyalgia have been the tricyclic antidepressants, medications traditionally used in treating depression. In treating fibromyalgia, tricyclic antidepressants are taken at bedtime in doses that are a fraction of those used for treating depression and actually can be beneficial as sleep aids. Tricyclic antidepressants appear to reduce fatigue, relieve muscle pain and spasm, and promote deep, restorative sleep in patients with fibromyalgia. Scientists believe that tricyclics work by interfering with a nerve transmitter chemical in the brain called serotonin. Examples of tricyclic antidepressants commonly used in treating fibromyalgia include amitriptyline (Elavil) and doxepin (Sinequan).
There is no method of preventing fibromyalgia. Exacerbations of fibromyalgia can be minimized with exercise, promotion of optimal sleep, stress reduction, and proper medical treatment.
The Future of Treatments and Therapy
The key to unlocking the mystery of fibromyalgia has yet to be found. Research scientists have been studying numerous viruses as potential causes for fibromyalgia. Identification of an infectious agent or toxin which causes the disease may one day lead to a laboratory test that can help doctors diagnose fibromyalgia. Specific fibromyalgia treatment aimed at a cure awaits future research that uncovers the exact cause of the disease.
Recent scientific studies suggest that a specific area of the brain called the insula may be involved in the pathophysiology of fibromyalgia. New drugs may be developed that block substance P or nerve growth factor to relieve pain of fibromyalgia. Many fibromyalgia patients can be helped by improved patient education, proper exercise, and medications. With ongoing research, the future prognosis will certainly improve for those affected by fibromyalgia.
RM Hochella
Modern Health Perspectives
Support Groups and References
Arthritis Foundation
PO Box 19000
Atlanta, GA 30326
National Fibromyalgia Association
American Fibromyalgia Syndrome Association
References
Klippel, John H., et al., eds. Primer on the Rheumatic Diseases. 13th ed. New York: Springer and Arthritis Foundation, 2008.
Rao, Srinivas G., Judith F. Gendreau, and Jay D. Kranzler. “Understanding the Fibromyalgia Syndrome.” Psychopharmacol Bull. 40.4 (2008): 24-56.
This gallery contains 0 photos